Skip to main content
×
Home
    • Aa
    • Aa

Nutritional Aspects of Aluminium Toxicity

  • Gordon L. Klein (a1)
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Nutritional Aspects of Aluminium Toxicity
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      Nutritional Aspects of Aluminium Toxicity
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      Nutritional Aspects of Aluminium Toxicity
      Available formats
      ×
Abstract
Copyright
References
Hide All
Ackrill P., Ralston A. J. & Day J. P. (1986). Role of desferrioxamine in the treatment of dialysis encephalopathy. Kidney International 29 Suppl 18, S104S107.
Alfrey A. C. (1980). Aluminum metabolism in uremia. Neurotoxicology 1, 4353.
Alfrey A. C. (1983). Aluminum. Advances in Clinical Chemistry 23, 6991.
Alfrey A. C. (1985). The case against aluminum affecting parathyroid function. American Journal of Kidney Diseases 6, 309312.
Alfrey A. C. (1986). Dialysis encephalopathy. Kidney International 29, Suppl. 18, S53S57.
Alfrey A. C., Hegg A. & Craswell P. (1980). Metabolism and toxicity of aluminum in renal failure. American Journal of Clinical Nutrition 33, 15091516.
Alfrey A. C., LeGendre G. R. & Kaehny W. D. (1976). The dialysis encephalopathy syndrome. Possible aluminum intoxication. New England Journal of Medicine 294, 184188.
Alfrey A. C., Mishell M., Burks J., Contiguglia S. R., Rudolph H., Lewin E. & Holmes J. H. (1972). Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Transactions of the American Society for Artificial Internal Organs 18, 257261.
Andreoli S. P., Bergstein J. M. & Sherrard D. J. (1984). Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis. New England Journal of Medicine 310, 10791084.
Andress D., Felsenfeld A. J., Voigts A. & Llach F. (1983). Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia. Kidney International 24, 364370.
Andress D. L., Ott S. M., Maloney N. A. & Sherrard D. J. (1985). Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure. New England Journal of Medicine 312, 468473.
Bakir A. A., Hryhorczuk D. D., Berman E. & Dunea G. (1986). Acute fatal hyperaluminemic encephalopathy in undialyzed and recently dialyzed uremic patients. Transactions of the American Society for Artificial Internal Organs 32, 171176.
Balistreri W. F., Novak D. A. & Farrell M. K. (1986). Bile acid metabolism, total parenteral nutrition, and cholestasis. In Total Parenteral Nutrition: Indications, Utilization, Complications, and Pathophysiological Considerations, pp. 319334 [Lebenthal E., editor]. New York: Raven Press.
Banks W. A. & Kastin A. J. (1983). Aluminium increases permeability of the blood–brain barrier to labelled DSIP and β-endorphin: possible implications for senile and dialysis dementia. Lancet ii, 12271229.
Bengoa J. M., Sitrin M. D., Wood R. J. & Rosenberg I. H. (1983). Amino acid-induced hypercalciuria in patients on total parenteral nutrition. American Journal of Clinical Nutrition 38, 264269.
Bidlack W. R., Brown R. C., Meskin M. S., Lee T. C. & Klein G. L. (1987). Effect of aluminum on the hepatic mixed function oxidase and drug metabolism. Drug–Nutrient Interactions 5, 3342.
Blair H. C., Finch J. L., Avioli R., Crouch E. C., Slatopolsky E. & Teitelbaum S. L. (1989). Micromolar aluminum levels reduce 3H-thymidine incorporation by cell line UMR 106-01. Kidney International 35, 11191125.
Bourdeau A. M., Plachot J. J., Cournot-Witmer G., Pointillart A., Balsan S. & Sachs C. (1987). Parathyroid response to aluminum in vitro: ultrastructural changes andPTH release. Kidney International 31 1524.
Bournerais F., Monnier N. & Reveillaud R. J. (1983). Risk of orally administered aluminum hydroxide and results of withdrawal. Proceedings of the European Dialysis and Transplantation Association 20, 207212.
Brun A. & Dictor M. (1981). Senile plaques and tangles in dialysis dementia. Acta Pathologica et Microbiologica Scandinavica A 89, 193198.
Buchanan M. R. C., Ihle B. U. & Dunn C. M. (1981). Hemodialysis related osteomalacia: a staining method to demonstrate aluminum. Journal of Clinical Pathology 34, 13521354.
Burks J. S., Alfrey A. C., Huddleston J., Norenberg M. D. & Lewin E. (1976). A fatal encephalopathy in chronic haemodialysis patients. Lancet i, 764768.
Cann C. E., Prussin S. G. & Gordan G. S. (1979). Aluminum uptake by the parathyroid glands. Journal of Clinical Endocrinology and Metabolism 49, 543545.
Carlisle E. M. & Curran M. J. (1987). Interrelationship between silicon and aluminum in the rat. Federation Proceedings 46, 755 Abstr.
Carmichael K. A., Fallon M. D., Dalinka M., Kaplan F. S., Axel L. & Haddad J. G. (1984). Osteomalacia and osteitis fibrosa in a man ingesting aluminum hydroxide antacid. American Journal of Medicine 76, 11371143.
Chan Y. L., Alfrey A. C., Posen S., Lissner D., Hills E., Dunstan C. R. & Evans R. A. (1983). Effect of aluminum on normal and uremic rats: tissue distribution, vitamin D metabolites and quantitative bone histology. Calcified Tissue International 35, 344351.
Clarkson E. M., Luck V. A., Hynson W. V., Bailey R. R., Eastwood J. B., Woodhead J. S., Clements V. R., O'Riordan J. L. H. & de Wardener H. E. (1972). The effect of aluminium hydroxide on calcium, phosphorus, and aluminium balances, the serum parathyroid hormone concentration and the aluminium content of bone in patients with chronic renal failure. Clinical Science 43, 519531.
Committee on Nutrition, American Academy of Pediatrics (1986). Aluminum toxicity in infants and children. Pediatrics 78, 11501154.
Cournot-Witmer G., Zingraff J., Plachot J. J., Escaig F., Lefèvre R., Boumati P., Bourdeau A., Garabèdian M., Galle P., Bourdon R., Drüeke T. & Balsan S. (1981). Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization. Kidney International 20, 375385.
Crapper D. R., Quittkat S., Krishnan S. S., Dalton A. J. & De Boni U. (1980). Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy. Acta Neuropathologica 50, 1924.
DeBoni U., Seger M. & McLachlan Crapper D. R. (1980). Functional consequences of chromatin bound aluminum in cultured human cells. Neurotoxicology 1, 6581.
Demontis R., Reissi D., Boudailliez B., Westeel P. F., Leflon P., Brasseur J., Coevoet B. & Fournier A. (1989). Indirect clinical evidence that 1-αOH vitamin D3 increases the intestinal absorption of aluminum. Clinical Nephrology 31, 123127.
deVernejoul M. C., Messing B., Modrowski D., Bielakoff J., Buisine A. & Miravet L. (1985). Multifactorial low remodeling bone disease during cyclic total parenteral nutrition. Journal of Clinical Endocrinology and Metabolism 60, 109113.
DiJoseph J. F., Borella L. E. & Mir Nabi G. (1989). Activated aluminum complex derived from solubilized antacids exhibits enhanced cytoprotective activity in rat. Gastroenterology 96, 730735.
Ellis H. A., McCarthy J. H. & Herrington J. (1979). Bone aluminum in hemodialyzed patients and in rats injected with aluminum chloride: relationship to impaired bone mineralization. Journal of Clinical Pathology 32, 832844.
Fanti P., Faugere M. C., Smith A. J. & Malluche H. H. (1987). Removal of aluminum (Al) is associated with increased production of 1,25(OH)2 vit D in dialysis patients. Kidney International 31, 346 Abstr.
Fell G. S., Shenkin A. & Halls D. J. (1986). Aluminium contamination of intravenous pharmaceuticals, nutrients, and blood products. Lancet i, 380.
Felsenfeld A. J., Rodriguez M., Coleman M., Ross D. & Llach F. (1989). Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease. Kidney International 35, 13711378.
Fisher C. E., Knowles M. E., Massey R. C. & McWeeny D. J. (1989). Levels of aluminium in infant formulae. Lancet i, 1024.
Freundlich M., Zilleruelo G., Abitbol C., Strauss J., Faugere M.-C. & Malluche H. H. (1985). Infant formula as a cause of aluminium toxicity in neonatal uraemia. Lancet ii, 527529.
Galceran T. J., Finch J., Bergfeld M., Coburn J. W., Teitelbaum S., Martin K. & Slatopolsky E. (1987). Biological effects of aluminum on normal dogs: studies on isolated perfused bone. Endocrinology 121, 406413.
Galle P. & Giudicelli C. P. (1982). [Electron microprobe ultrastructural localization of aluminium in hepatocytes. Nouvelle Presse Médicale 11, 11231125.
Garruto R. M., Yanagihara R., Shankar S., Wolff A., Salazar A. M., Amyx H.L. & Gajdusek D. C. (1988). Experimental models of metal-induced neurofibrillary degeneration. In Amyotrophic Lateral Sclerosis, pp. 4150. [Tsubaki T. and Yase Y., editors]. Amsterdam: ElsevierScience Publishers.
Glinert R. J. & Burnatowska-Hledin M. (1988). Serum and urinary aluminum levels in patients receiving alumprecipitated allergenic extracts. Annals of Allergy 61, 433435.
Godsall J. W., Baron R. & Insogna K. L. (1984). Vitamin D metabolism and bone histomorphometry in a patient with antacid-induced osteomalacia. American Journal of Medicine 77, 747750.
Goodman W. G. (1984). Short-term aluminum administration in the rat: reductions in bone formation without osteomalacia. Journal of Laboratory and Clinical Medicine 103, 749757.
Goodman W. G., Gilligan J. & Horst R. L. (1984 a). Short-term aluminum administration in the rat: effects on bone formation and relationship to renal osteomalacia. Journal of Clinical Investigation 73, 171181.
Goodman W. G., Henry D. A., Horst R. L., Nudelman R. K., Alfrey A. C. & Coburn J. W. (1984 b). Parenteral aluminum administration in the dog. II. Induction of osteomalacia and effect on vitamin D metabolism. Kidney International 25, 370375.
Gorsky J. E., Dietz A. A., Spencer H. & Osis D. (1979). Metabolic balance of aluminum studied in six men. Clinical Chemistry 25, 17391743.
Greger J. L. & Baier M. J. (1983 a). Excretion and retention of low or moderate levels of aluminium by human subjects. Food and Chemical Toxicology 21, 473476.
Greger J. L. & Baier M. J. (1983 b). Effect of dietary aluminum on mineral metabolism of adult males. American Journal of Clinical Nutrition 38, 411419.
Hem J. D. (1986). Geochemistry and aqueous chemistry of aluminum. Kidney International 29, Suppl. 18, S3S7.
Henry D. A., Goodman W. G., Nudelman R. K., DiDomenico N. D., Alfrey A. C., Slatopolsky E. & Coburn J. W. (1984). Parenteral aluminum administration in the dog. I. Plasma kinetics, tissue levels, calcium metabolism and parathyroid hormone. Kidney International 25, 362369.
Henry H. L. & Norman A. W. (1985). Interactions between aluminum and the actions and metabolism of vitamin D3 in the chick. Calcified Tissue International 37, 484487.
Hodsman A. B., Sherrard D. J., Wong E. G. C., Brickman A. S., Lee D. B. N., Alfrey A. C., Singer F. R., Norman A. W. & Coburn J. W. (1981). Vitamin D resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism: description of the syndrome in 19 patients. Annals of Internal Medicine 94, 629637.
Ittel T. H., Buddington B., Miller N. L. & Alfrey A. C. (1987). Enhanced gastrointestinal absorption of aluminum in uremic rats. Kidney International 32, 821826.
Ittel T. H., Kluge R. & Sieberth H. G. (1988). Enhanced gastrointestinal absorption of aluminum in uraemia: time course and effect of vitamin D. Nephrology, Dialysis, Transplantation 3, 617623.
Jeffery E. H., Jansen H. T. & Dellinger J. A. (1987). In vivo interactions of aluminum with hepatic cytochrome P-450 and metallothionein. Fundamental and Applied Toxicology 8, 541548.
Kaehny W. D., Hegg A. P. & Alfrey A. C. (1977). Gastrointestinal absorption of aluminum from aluminum-containing antacids. New England Journal of Medicine 296, 13891390.
Kirschbaum B. B. & Schoolwerth A. C. (1989). Acute aluminum toxicity associated with oral citrate and aluminum-containing antacids. American Journal of Medical Sciences 297, 911.
Klatzo I., Wisniewski H. & Streicher E. (1965). Experimental production of neurofibrillary degeneration. I. Light microscopic observations. Journal of Neuropathology and Experimental Neurology 24, 187199.
Klein G. L. (1990). Unusual sources of aluminum. In Aluminum and Renal Failure, pp. 203211 [DeBroe M. E. and Coburn J. W., editors]. Dordrecht: Kluwer Academic Publishers.
Klein G. L., Alfrey A. C., Miller N. L., Sherrard D. J., Hazlet T. K., Ament M. E. & Coburn J. W. (1982 a). Aluminum loading during total parenteral nutrition. American Journal of Clinical Nutrition 35, 14251429.
Klein G. L., Ament M. E., Slatopolsky E. & Coburn J. W. (1985 a). Urinary mineral excretion during long-term total parenteral nutrition. In Metabolic Bone Disease in Total Parenteral Nutrition, pp. 103128 [Coburn J. W. and Klein G. L., editors]. Baltimore/Munich: Urban and Schwarzenberg.
Klein G. L., Berquist W. E., Ament M. E., Coburn J. W., Miller N. L. & Alfrey A. C. (1984). Hepatic aluminum accumulation in children on total parenteral nutrition. Journal of Pediatric Gastroenterology and Nutrition 3, 740743.
Klein G. L., Heyman M. B., Lee T. C., Miller N. L., Marathe G., Gourley W. K. & Alfrey A. C. (1988). Aluminum associated hepatobiliary dysfunction in rats: relationships to dosage and duration of exposure. Pediatric Research 23, 275278.
Klein G. L., Horst R. L., Alfrey A. C. & Slatopolsky E. (1985 b). Serum levels of 1,25-dihydroxyvitamin D in children on parenteral nutrition with reduced aluminum content. Journal of Pediatric Gastroenterology and Nutrition 4, 9396.
Klein G. L., Horst R. L., Norman A. W., Ament M. E., Slatopolsky E. & Coburn J. W. (1981). Reduced serum levels of 1-alpha,25-dihydroxy vitamin D during long-term total parenteral nutrition. Annals of Internal Medicine 94, 638643.
Klein G. L., Horst R. L., Slatopolsky E., Kurokawa K., Alfrey A. C., Ament M. E. & Coburn J. W. (1985 c). Attempts to modify PTH and vitamin D status in patients receiving long-term total parenteral nutrition. In Metabolic Bone Disease in Total Parenteral Nutrition, pp. 91100. [Coburn J. W. and Klein G. L., editors]. Baltimore/Munich: Urban and Schwarzenberg.
Klein G. L., Lee T. C., Bishop J. E., Vaccaro M. L., Jongen M., Kurokawa K., Coburn J. W. & Norman A. W. (1986). The effects of aluminum loading on the renal response to parathyroid hormone in the vitamin D-replete rat. Biochemical Medicine and Metabolic Biology 36, 363368.
Klein G. L., Lee T. C., Heyman M. B. & Rassin D. K. (1989 b). Altered glycine and taurine conjugation of bile acids following aluminum administration to rats. Journal of Pediatric Gastroenterology and Nutrition 9, 361364.
Klein G. L., Lee T. C., Mann P. A., Miller N. L. & Alfrey A. C. (1989 a). Effects of aluminum on the liver following high-dose enteral administration to rats. Journal of Pediatric Gastroenterology and Nutrition 9, 105107.
Klein G. L., Ott S. M., Alfrey A. C., Sherrard D. J., Hazlet T. K., Miller N. L., Maloney N. A., Berquist W. E., Ament M. E. & Coburn J. W. (1982 b). Aluminum as a factor in the bone disease of long-term parenteral nutrition. Transactions of the Association of American Physicians 95, 155164.
Klein G. L., Sedman A. B., Heyman M. B., Marathe G., Battifora H. A., Worrall J. L., Horst R. L., Brewer G. J., Miller N. L. & Alfrey A. C. (1987). Hepatic abnormalities associated with aluminum loading in piglets. Journal of Parenteral and Enteral Nutrition 11, 293297.
Klein G. L., Sedman A. B., Merritt R. J. & Alfrey A. C. (1985 d). Tissue aluminum loading in premature infants on intravenous therapy: a possible cause of osteopenia. Clinical Research 33, 140A Abstr.
Klein G. L., Snodgrass W. R., Griffin M. P., Miller N. L. & Alfrey A. C. (1989 c). Hypocalcemia complication deferoxamine therapy in an infant with parenteral nutrition-associated aluminum overload: evidence for a role of aluminum in the bone disease of infants. Journal of Pediatric Gastroenterology and Nutrition 9, 400403.
Klein G. L., Targoff C. M., Ament M. E., Sherrard D. J., Bluestone R., Young J. H., Norman A. W. & Coburn J. W. (1980). Bone disease associated with total parenteral nutrition. Lancet ii, 10411044.
Koo W. W. K., Kaplan L. A., Bendon R., Succop P., Tsang R. C., Horn J. & Steichen J. J. (1986 b). Response to aluminum in parenteral nutrition during infancy. Journal of Pediatrics 109, 883887.
Koo W. W. K., Kaplan L. A., Horn J., Tsang R. C. & Steichen J. J. (1986 c). Aluminum in parenteral solutions – sources and possible alternatives. Journal of Parenteral and Enteral Nutrition 10, 591595.
Koo W. W. K., KaplanL A. & Krug-Wispe S. K. (1988). Aluminum contamination of infant formulas. Journal of Parenteral and Enteral Nutrition 12, 170173.
Koo W. W. K., Oestreich A., Tsang R. C., Sherman R. & Steichen J. (1986 a). Natural history of rickets and fractures in very low birth weight (VLBW) infants during infancy. Journal of Bone and Mineral Research 1, 123 Abstr. 255.
Kopeloff L. M., Barrera S. E. & Kopeloff N. (1942). Recurrent convulsive seizures in animals produced by immunologic and chemical means. American Journal of Psychiatry 98, 881902.
Kovalchik M. T., Kaehny W. D., Jackson T. & Alfrey A. C. (1978). Aluminum kinetics during hemodialysis. Journal of Laboratory and Clinical Medicine 92, 712716.
Kraut J. A., Shinaberger J. H., Singer F. R., Sherrard D. J., Saxton J., Miller J. H., Kurokawa K. & Coburn J. W. (1983). Parathyroid gland responsiveness to acute hypocalcemia in dialysis osteomalacia. Kidney International 23, 725730.
Lawson M., Milla P. J. & Harper J. L. (1989). Aluminium and infant formulae. Lancet i, 614615.
Lewis-Finch J., Bergfeld M., Martin K., Teitelbaum S. & Slatopolsky E. (1986). Hypoparathyroidism is essential for development of aluminum-induced osteomalacia in rats. Kidney International 29, 218 Abstr.
Lieberherr M., Grosse B., Cournot-Witmer G., Herman-Erlee M. P. M. & Balsan S. (1987). Aluminum action on mouse bone cell metabolism and response to PTH and 1,25 (OH)2D3. Kidney International 31, 736743.
Litov R. E., Sickles V. S., Chan G. M., Springer M. A. & Cordano A. (1989). Plasma aluminum measurements in term infants fed human milk or a soy-based infant formula. Pediatrics 84, 11051107.
Llach F., Felsenfeld A. J., Coleman M. D., Keveney J. J., Pederson J. A. & Medlock T. R. (1986). The natural course of dialysis osteomalacia. Kidney International 29, Suppl. 18, S74S79.
London G. M., deVernejoul M. C., Fabiani F., Marchais S., Guerin A., Metivier F., Chappais P. & Llach F. (1989). Association between aluminum accumulation and cardiac hypertrophy in hemodialyzed patients. American Journal of Kidney Diseases 13, 7583.
Long J. F., Nagode L. A., Kindig O. & Liss L. (1980). Axonal swellings of Purkinje cells in chickens associated with high intake of 1,25(OH)2D3 and elevated dietary aluminum includingx-ray microanalysis. Neurotoxicology 1, 111120.
McGraw M., Bishop N., Jameson R., Robinson M. J., O'Hara M., Hewitt C. D. & Day J. P. (1986). Aluminum content of milk formulae and intravenous fluids used in infants. Lancet i, 157.
Malluche H. H., Faugere M.-C., Friedler R. M., Matthews C. & Fanti P. (1987). Calcitriol, parathyroid hormone, and accumulation of aluminum in bone in dogs with renal failure. Journal of Clinical Investigation 79, 754761.
Marquis J. K. & Black E. E. (1984). Aluminum activation and inactivation of bovine caudate acetyl-cholinesterase. Bulletin of Environmental Contamination and Toxicology 32, 704710.
Martin R. B., Savory J., Brown S., Bertholf R. L. & Wills M. R. (1987). Transferrin binding of Al3+ and Fe3+. Clinical Chemistry 33, 405407.
Martyn C. N., Barker D. J. P., Osmond C., Harris E. C., Edwardson J. A. & Lacey R. F. (1989). Geographical relation between Alzheimer's disease and aluminium in drinking water. Lancet i, 5962.
May J. C., Rains T. C., Maienthal F. J., Biddle G. N. & Progar J. J.(1986). A survey of the concentrations of eleven metals in vaccines, allergenic extracts, toxoids, blood, blood derivatives and other biological products. Journal of Biological Standardization 14, 363375.
Mayor G. H., Keiser J. A., Makadons D. & Ku P. (1977). Aluminum absorption and distribution: effect of parathyroid hormone. Science 197, 11871189.
Mayor G. H., Sprague S. M., Hourani M. R. & Sanchez T. V. (1980). Parathyroid hormone-mediated aluminum deposition and egress in the rat. Kidney International 17, 4044.
Meyer J. L., & Thomas W. C. (1986). Aluminum and aluminum complexes. Effect on calcium phosphate precipitation. Kidney International 29, Suppl. 18, S20S23.
Milliner D. S., Shinaberger J. H., Shuman P. & Coburn J. W. (1985). Inadvertent aluminum administration during plasmaexchange due to aluminum contamination of albumin-replacement solutions.New England Journal of Medicine 312, 165167.
Morrissey J., Rothstein M., Mayor G. & Slatopolsky E. (1983). Suppression of parathyroid hormone secretion by aluminum. Kidney International 23, 699704.
Nebeker H. G., Andress D. L., Ott S. M., Alfrey A. C., Slatopolsky E., Sherrard D. J. & Coburn J. W. (1987). Treatment of aluminum-related bone disease with deferoxamine: results in 51 cases. International Congress of Nephrology 10, London Abstr.
Nordal K. P., Dahl E., Thomassen Y., Brodwall E. K. & Halse J. (1988). Seasonal variations in serum aluminum concentration. Pharmacology and Toxicology 62, 8083.
Ott S. M., Andress D. L., Nebeker H. G., Milliner D. S., Maloney N. A., Coburn J. W. & Sherrard D. J. (1986). Changes in bone histology after treatment with desferrioxamine. Kidney International 29, Suppl. 18, S108S113.
Ott S. M., Feist E., Andress D. L., Liu C. C., Sherrard D. J., Alfrey A. C., Slatopolsky E. & Howard G. A. (1987). Development and reversibility of aluminum-induced bone lesion in the rat. Journal of Laboratory and Clinical Medicine 109, 4047.
Ott S. M., Maloney N. A., Coburn J. W., Alfrey A. C. & Sherrard D. J. (1982). The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. New England Journal of Medicine 307, 709713.
Ott S. M., Maloney N. A., Klein G. L., Alfrey A. C., Ament M. E., Coburn J. W. & Sherrard D. J. (1983). Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition. Annals of Internal Medicine 98, 910914.
Parkinson I. S., Ward M. K., Feest T. G., Fawcett R. W. P. & Kerr D. N. S. (1979). Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey. Lancet i, 406409.
Perl D. P. & Brody A. R. (1980). Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science 208, 297299.
Perl D. P., Gajdusek D. C., Garruto R. M., Yanagihara R. T. & Gibbs C. J. (1982). Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Science 217, 10531055.
Perl D. P. & Good P. F. (1987). Uptake of aluminium into central nervous system along nasal-olfactory pathways. Lancet i, 1028.
Pierides A. M., Edwards W. G., Cullum U. X., McCall J. T. & Ellis H. A. (1980). Hemodialysis encephalopathy with osteomalacic fractures and muscles weakness. Kidney International 18, 115124.
Plachot J. J., Cournot-Witmer G., Halpern S., Mendes V., Bourdeau A., Fritsch J., Bourdon R., Drueke T., Galle P. & Balsan S. (1984). Bone ultrastructure and X-ray microanalysis of aluminum-intoxicated hemodialyzed patients. Kidney International 25, 796803.
Platts M. M., Goode G. C. & Hislop J. S. (1977). Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis. British Medical Journal ii, 657660.
Posner A. S., Blumenthal N. C. & Boskey A. L. (1986). Model of aluminum-induced osteomalacia: inhibition of apatite formation and growth. Kidney International 29, Suppl. 18, S17S19.
Quarles L. D., Castillo S. R. & Drezner M. K. (1989 a). Aluminum-induced replication of osteoblast precursors: a potential mechanism underlying neo-osteogenesis. Journal of Bone and Mineral Research 4, Suppl. 1, S131 Abstr.
Quarles L. D., Gitelman H. J. & Drezner M. K. (1989 b). Aluminum-induced de novo bone formation in the beagle: a parathyroid hormone-dependent event. Journal of Clinical Investigation 83, 16441650.
Recker R. R., Blotcky A. J., Leffler J. A. & Rack E. P. (1977). Evidence for aluminum absorption from the gastrointestinal tract and bone deposition by aluminum carbonate ingestion with normal renal function. Journal of Laboratory and Clinical Medicine 90, 810815.
Ribak C. E., Harris A. B., Vaughn J. E. & Roberts E. (1979). Inhibitory, GABAergic nerve terminals decrease at sites of focal epilepsy. Science 205, 211214.
Robertson J. A., Felsenfeld A. J., Haygood C. C., Wilson P., Clark C. & Llach F. (1983). An animal model of aluminum-induced osteomalacia: role of chronic renal failure. Kidney International 23, 327335.
Sabouraud O., Chatel M., Menault F., Dien-Peron J., Cartier F., Garre M., Gary J. & Pecker S. (1978). [Progressivè myoclonic dialysis encephalopathy: clinical, electroencephalographic and neuropathological study. Discussion of pathogenesis.] Revue Neurologique 134, 575600.
Salusky I. B., Coburn J. W., Brill J., Foley J., Slatopolsky E., Fine R. N. & Goodman W. G. (1988). Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney International 33, 975982.
Salusky I. B., Coburn J. W., Nelson P. & Goodman W. G. (1990). Prospective evaluation of aluminum loading from formula in infants with uremia. Journal of Pediatrics 116, 726729.
Salusky I. B., Coburn J. W., Paunier L., Sherrard D. J. & Fine R. M. (1984). Role of aluminum hydroxide in raising serum aluminum levels in children undergoing continuous ambulatory peritoneal dialysis. Journal of Pediatrics 105, 717720.
Scholtz C. L., Swash M., Gray A., Kogeorgos J. & Marsh F. (1987). Neurofibrillary neuronal degeneration in dialysis dementia: a feature of aluminum toxicity. Clinical Neuropathology 6, 9397.
Sedman A. B., Alfrey A. C., Miller N. L. & Goodman W. G. (1987). Tissue and cellular basis for impaired bone formation in aluminum-related osteomalacia in the pig. Journal of Clinical Investigation 79, 8692.
Sedman A. B. & Klein G. L. (1990). Aluminum toxicity in childhood. In Aluminum and Renal Failure, pp. 267274 [DeBroe M. E. and Coburn J. W., editors]. Dordrecht: Kluwer Academic Publishers.
Sedman A. B., Klein G. L., Merritt R. J., Miller N. L., Weber K. O., Gill W. L., Anand H. & Alfrey A. C. (1985). Evidence of aluminum loading in infants receiving intravenous therapy. New England Journal of Medicine 312, 13371343.
Sedman A. B., Wilkening G. W., Warady B. A., Lum G. M. & Alfrey A. C. (1984). Encephalopathy in childhood secondary to aluminum toxicity. Journal of Pediatrics 105, 836838.
Semmerkrot B. A., Monnens L. A. H. & Baadenhuysen H. (1989). Levels of aluminium in infant formulae. Lancet i, 10241025.
Shankar S. K., Yanagihara R., Garruto R. M., Grundke-Iqbal I., Kosik K. S. & Gajdusek D. C. (1989). Immunocytochemical characterization of neurofibrillary tangles in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Annals of Neurology 25, 146151.
Shike M., Shils M. E., Heller A., Alcock N., Vigorita V., Brockman R., Holick M. F., Lane J. & Flombaum C. (1986). Bone disease in prolonged parenteral nutrition: osteopenia without mineralization defect. American Journal of Clinical Nutrition 44, 8998.
Shike M., Sturtridge W. C., Tam C. S., Harrison J. E., Jones G., Murray T. M., Husdan H., Whitwell J., Wilson D. R. & Jeejeebhoy K. N. (1981). A possible role of vitamin D in the genesis of parenteral nutrition-induced metabolic bone disease. Annals of Internal Medicine 95, 560568.
Short A. I. K., Winney R. J. & Robson J. S. (1980). Reversible microcytic hypochromic anaemia in dialysis patients due to aluminum intoxication. Proceedings of European Dialysis and Transplantation Association 17, 226233.
Siegel N., Suhayda C. & Haug A. (1982). Aluminum changes the conformation of calmodulin. Physiological Chemistry and Physics 14, 165167.
Simmons D. J., Seitz P., Kidder L. S., Klein G. L., Waeltz M., Gundberg C. M., Tabuchi C., Yang C.-Y. & Zhang R.-W. (1991). Partial characterization of the rat marrow stromal cell. Calcified Tussue International.
Slanina P., Falkeborn Y., Frech W. & Cedergren A. (1984). Aluminum concentrations in the brain and bone of rats fed citric acid, aluminium citrate or aluminium hydroxide. Food and Chemical Toxicology 22, 391397.
Slanina P., Frech W., Bernhardson Å., Cedergren A. & Mattsson P. (1985). Influence of dietary factors on aluminum absorption and retention in the brain and bone of rats. Acta Pharmacologica et Toxicologica 56, 331336.
Slanina P., Frech W., Ekström L-G., Lööf L., Slorach S. & Cedergren A. (1986). Dietary citric acid enchances absorption of aluminum in antacids. Clinical Chemistry 32, 539541.
Smith J. B. (1984). Aluminum ions stimulate DNA synthesis in quiescent cultures of Swiss3T3 and 3T6 cells. Journal of Cellular Physiology 118, 298304.
Terry R. D. & Peña C. (1965). Experimental production of neurofibrillary degeneration. II. Electron microscopy, phcsphatase histochemistry and electron probe analysis. Journal of Neuropathology and Experimental Neurology 24, 200210.
Trapp G. A. (1986). Interactions of aluminum with cofactors, enzymes, and other proteins. Kidney International 29, Suppl. 18, S12S16.
Uemura E. (1984). Intranuclear aluminum accumulation in chronic animals with experimental neurofibrillary changes. Experimental Neurology 85, 1018.
Vargas J. H., Klein G. L., Ament M. E., Ott S. M., Sherrard D. J., Horst R. L., Berquist W. E., Alfrey A. C., Slatopolsky E. & Coburn J. W. (1988). Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content. American Journal of Clinical Nutrition 48, 10701078.
Vukičević S., Krempien B. & Stavljenić A. (1987). Effects of 1-α, 25- and 24 R25-dihydroxyvitamin D3 on aluminum-induced rickets in growing uremic rats. Journal of Bone and Mineral Research 2, 533545.
Vukičević S. & Stavljenić A. (1989). Aluminum accumulates on inactive bonesurfaces after parathyroidectomy in uremic rats. Hormone and Metabolic Research 21, 1517.
Weberg R. & Berstad A. (1986). Gastrointestinal absorption of aluminium from single doses of aluminium containing antacids in man. European Journal of Clinical Investigation 16, 428432.
Wenk G. L. & Stemmer K. L. (1983). Suboptimal dietary zinc intake increases aluminum accumulation into the rat brain. Brain Research 288, 393395.
Williams J. W., Vera S. R., Peters T. G., Luther R. W., Bhattacharya S., Spears H., Graham A., Pitcock J. A. & Crawford A. J. (1986). Biliary excretion of aluminum in aluminum osteodystrophy with liver disease. Annals of Internal Medicine 104, 782785.
Wills M. R. & Savory J. (1989). Aluminum and chronic renal failure: sources, absorption, transport, and toxicity. Critical Reviews in Clinical Laboratory Sciences 27, 59107.
Wisniewski H. M., Shek J. W., Gruca S. & Sturman J. A. (1984). Aluminium-induced neurofibrillary changes in axons and dendrites. Acta Neuropathologica 63, 190197.
Yase Y. (1988). Metal studies of ALS-further development. In Amyotrophic Lateral Sclerosis, pp. 5966 [Tsubaki T. and Yase Y., editors]. Amsterdam: Elsevier Science Publishers.
Yokel R. A. (1984). Toxicity of aluminum exposure during lactation to the maternal and suckling rabbit. Toxicology and Applied Pharmacology 75, 3543.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Nutrition Research Reviews
  • ISSN: 0954-4224
  • EISSN: 1475-2700
  • URL: /core/journals/nutrition-research-reviews
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 44 *
Loading metrics...

Abstract views

Total abstract views: 74 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 20th October 2017. This data will be updated every 24 hours.